Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
BJDX•Enrollment completed in Symon-II study
July 21 (Reuters) - Bluejay Diagnostics Inc. BJDX.O:
- Bluejay Diagnostics announces successful completion of enrollment in the Symon-II multicenter clinical validation study
- Bluejay Diagnostics - preliminary Symon-II data show 17% 28-day mortality rate
